TuberculosisArchives
Diagnostic dilemma of a new endobronchial lesion in a patient on anti-tuberculosis regimen: unveiling tuberculosis immune reconstitution inflammatory syndrome
Tuberculosis 3 min.
Tuberculosis (TB) is a prevalent and curable disease caused by the bacillus Mycobacterium tuberculosis (MTB) which affects more than 10 million people per year [1]. Eradication of MTB requires tumor necrosis factor alpha (TNF-α) mediated activation of effector T cells which release...
Tuberculosis in children and adolescents using biological agents: a nationwide cohort study from Turkey
Tuberculosis 4 min.
Biological agents, especially tumor necrosis factor-α (TNFα) blocking agents, have radically changed the therapeutic approach and disease courses, and nowadays they are used in various inflammatory and immune-mediated diseases [1, 2]. Biologic agents inhibit specific components of the immune...
Diagnostic utility of haematological parameters for tuberculosis in children living with HIV (0–14 years): a retrospective cohort study
Tuberculosis 4 min.
Tuberculosis (TB) remains a significant public health concern, particularly in resource-limited settings and among populations with compromised immune systems, such as those living with HIV/AIDS. Children living with HIV (CLHIV) are at an increased risk of developing TB, with a higher likelihood of disseminated...
Critical analysis of spirometry interpretation in tuberculosis-related lung function impairment: a commentary on a Chinese study
Tuberculosis 2 min.
We read with great interest the remarkable paper by Zhao et al. [1], titled “Analysis of clinical characteristics of different types of lung function impairment in TDL patients” which aimed to compare the severity of various lung function patterns (LFPs), such as restrictive and obstructive...
